Direct Oral Anticoagulants vs. Warfarin: 2025 Efficacy, Monitoring & Latest Insights

Discover how direct oral anticoagulants (DOACs) are changing blood thinning therapy in 2025. This article covers the efficacy, safety, and monitoring requirements for leading options like apixaban, rivaroxaban, and dabigatran, all compared to traditional warfarin. Get practical tips for choosing and using these medications effectively. Learn what recent data and clinical trends reveal about their use, and find out which patients might benefit most.